Goyette-Desjardins G - Search Results

1

Impact of Protein Glycosylation on the Design of Viral Vaccines.

Schön K, Lepenies B, Goyette-Desjardins G. Schön K, et al. Among authors: goyette desjardins g. Adv Biochem Eng Biotechnol. 2021;175:319-354. doi: 10.1007/10_2020_132. Adv Biochem Eng Biotechnol. 2021. PMID: 32935143 Review.

2

S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis.

Prado Acosta M, Goyette-Desjardins G, Scheffel J, Dudeck A, Ruland J, Lepenies B. Prado Acosta M, et al. Among authors: goyette desjardins g. Front Immunol. 2021 Mar 1;12:602067. doi: 10.3389/fimmu.2021.602067. eCollection 2021. Front Immunol. 2021. PMID: 33732234 Free PMC article.

3

Lectin-Mediated Bacterial Modulation by the Intestinal Nematode Ascaris suum.

Midha A, Goyette-Desjardins G, Goerdeler F, Moscovitz O, Seeberger PH, Tedin K, Bertzbach LD, Lepenies B, Hartmann S. Midha A, et al. Among authors: goyette desjardins g. Int J Mol Sci. 2021 Aug 14;22(16):8739. doi: 10.3390/ijms22168739. Int J Mol Sci. 2021. PMID: 34445445 Free PMC article.

4

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines.

Price NL, Goyette-Desjardins G, Nothaft H, Valguarnera E, Szymanski CM, Segura M, Feldman MF. Price NL, et al. Sci Rep. 2016 Apr 22;6:24931. doi: 10.1038/srep24931. Sci Rep. 2016. PMID: 27103188 Free PMC article.

5

A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host.

Harding CM, Nasr MA, Scott NE, Goyette-Desjardins G, Nothaft H, Mayer AE, Chavez SM, Huynh JP, Kinsella RL, Szymanski CM, Stallings CL, Segura M, Feldman MF. Harding CM, et al. Among authors: goyette desjardins g. Nat Commun. 2019 Feb 21;10(1):891. doi: 10.1038/s41467-019-08869-9. Nat Commun. 2019. PMID: 30792408 Free PMC article.

6

Murine Whole-Blood Opsonophagocytosis Assay to Evaluate Protection by Antibodies Raised Against Encapsulated Extracellular Bacteria.

Goyette-Desjardins G, Roy R, Segura M. Goyette-Desjardins G, et al. Methods Mol Biol. 2015;1331:81-92. doi: 10.1007/978-1-4939-2874-3_6. Methods Mol Biol. 2015. PMID: 26169736

7

Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Goyette-Desjardins G, Calzas C, Shiao TC, Neubauer A, Kempker J, Roy R, Gottschalk M, Segura M. Goyette-Desjardins G, et al. Infect Immun. 2016 Jun 23;84(7):2059-2075. doi: 10.1128/IAI.00139-16. Print 2016 Jul. Infect Immun. 2016. PMID: 27113360 Free PMC article.

8

A single amino acid polymorphism in the glycosyltransferase CpsK defines four Streptococcus suis serotypes.

Roy D, Athey TBT, Auger JP, Goyette-Desjardins G, Van Calsteren MR, Takamatsu D, Okura M, Teatero S, Alcorlo M, Hermoso JA, Segura M, Gottschalk M, Fittipaldi N. Roy D, et al. Sci Rep. 2017 Jun 22;7(1):4066. doi: 10.1038/s41598-017-04403-3. Sci Rep. 2017. PMID: 28642597 Free PMC article.

9

Capsular polysaccharide switching in Streptococcus suis modulates host cell interactions and virulence.

Okura M, Auger JP, Shibahara T, Goyette-Desjardins G, Van Calsteren MR, Maruyama F, Kawai M, Osaki M, Segura M, Gottschalk M, Takamatsu D. Okura M, et al. Among authors: goyette desjardins g. Sci Rep. 2021 Mar 22;11(1):6513. doi: 10.1038/s41598-021-85882-3. Sci Rep. 2021. PMID: 33753801 Free PMC article.

10

Streptococcus suis serotype 3 and serotype 18 capsular polysaccharides contain di-N-acetyl-bacillosamine.

Goyette-Desjardins G, Vinogradov E, Okura M, Takamatsu D, Gottschalk M, Segura M. Goyette-Desjardins G, et al. Carbohydr Res. 2018 Aug;466:18-29. doi: 10.1016/j.carres.2018.07.003. Epub 2018 Jul 7. Carbohydr Res. 2018. PMID: 30014879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page